American Pharmacy News
  • People
  • Innovation
  • Regulatory
  • Industry
  • Federal Issues
  • State Issues
  • Directory
  • People
  • Innovation
  • Regulatory
  • Industry
  • Federal Issues
  • State Issues
  • Directory
  • Home
  • »
  • Stories
  • »
  • American Pharmacy News Reports

Biota sells antibiotic program to Spero

American Pharmacy News Reports | Mar 25, 2016
Biota has agreed to sell its antibotic program to Spero

Biota Pharmaceuticals has announced the completed sale of its assets relating to its broad spectrum antibiotic program to a new subsidiary of Spero Therapeutics LLC. Read More »

Discount Drug Mart adds get-out-the vote campaign to event

American Pharmacy News Reports | Mar 25, 2016
Discount Drug Mart recently added the get-out-the vite campaign to its pharmacists meeting

Discount Drug Mart Inc. recently hosted its biannual pharmacists meeting and promoted a get-out-the vote campaign with funding from the NACDS’ RxIMPACT. Read More »

McKesson announces launch of disaster recovery system

American Pharmacy News Reports | Mar 25, 2016
McKesson's recovery system will allow organizations to save its data and access it on multiple platforms

McKesson announced this week that it has launched its disaster recovery service that will help health care organizations uphold their mission-critical capabilities when disasters strike. Read More »

Walgreens Boot Alliance announces purchase of AmerisourceBergen shares

American Pharmacy News Reports | Mar 24, 2016

Walgreens Boots Alliance has announced that it has exercised warrants for the purchase of 22,696,912 common stock shares of AmerisourceBergen Corp. for a total payment of $1.17 billion. Read More »

ASHP publishes new special formations guide

American Pharmacy News Reports | Mar 24, 2016
More information about the ASHP third edition guide can be found on its website

The American Society of Health-System Pharmacists (ASHP) has published “Extemporaneous Formulations for Pediatric, Geriatric and Special Needs Patients” to aid in the treatment of patients who require medication dosages and forms that are not available commercially. Read More »

European Medicines Agency will review Pfizer’s Marketing Authorization Application for XELJANZ

American Pharmacy News Reports | Mar 24, 2016
Pfizer has announced that the European Medicines Agency will review its Marketing Authorization Application for XELJANZ

Pfizer has announced that the European Medicines Agency (EMA) has accepted its Marketing Authorization Application (MAA) for XELJANZ (tofacitinib citrate) for review. Read More »

FDA issues guidance for abuse-deterrent formulations

American Pharmacy News Reports | Mar 24, 2016
The FDA has issued guidelines for generic opioid drugs that contain abuse-deterrent formulations

The U.S. Food and Drug Administration (FDA) has issued a draft guidance that will help the pharmaceutical industry in its development of approved generic opioid drugs that contain abuse-deterrent formulations (ADF). Read More »

New campaign touts role of pharmacy benefit managers in reducing prescription costs

American Pharmacy News Reports | Mar 24, 2016

Pharmacy benefit managers could save labor unions, employers, government programs and consumers upwards of $654 billion during the next ten years, according to a new campaign launched by the Pharmaceutical Care Management Association (PCMA), the national group representing pharmacy benefit managers, or PBMs. Read More »

Patients with chronic conditions prefer home-delivered medications, new study shows

American Pharmacy News Reports | Mar 24, 2016

A new Kaiser Permanente study documents that stroke patients are more likely to take their prescribed medication when it is delivered to their home, proving patients want convenience. Read More »

AstraZeneca announces SOCRATES trial results

American Pharmacy News Reports | Mar 23, 2016
AstraZeneca has annoucned positive results from its SOCRATES trial

AstraZeneca today announced the results from the SOCRATES trial that examined the effectiveness of Brilinta/Brilique (ticagrelor) 90 mg tablets meant to be taken twice a day compared to aspirin100 mg once per day in patients suffering from acute ischemic stroke or transient ischemic attack (TIA). Read More »

ASHP publishes new clinical coordinator guide

American Pharmacy News Reports | Mar 23, 2016
The ASHP has published a new guide for clinical coordinators

The American Society of Health-System Pharmacists (ASHP) has published a step-by-step guide that is intended to help clinical coordinators and managers thrive in the workplace. Read More »

FDA approves Cinqair for asthma treatment

American Pharmacy News Reports | Mar 23, 2016
The FDA has approved Cinqair for the treatment of asthma

The U.S. Food and Drug Administration has approved Cinqair (reslizumab) for the treatment of severe asthma in combination with other asthma medicines in patients 18 years of age or older. Read More »

FDA approves Taltz to treat plaque psoriasis

American Pharmacy News Reports | Mar 23, 2016
The FDA has approved Taltz for the treatment of plaque psoriasis

The U.S. Food and Drug Administration (FDA) has approved Taltz (ixekizumab), which was designed for the treatment of adults with moderate-to-severe plaque psoriasis. Read More »

FDA approves Anthim for treatment of inhalational anthrax

American Pharmacy News Reports | Mar 22, 2016
The U.S. FDA has apporved Anthim for the treatment of inhalational anthrax

The U.S. Food and Drug Administration (FDA) announced this week the approval of Anthim (oblitoxaximab) injection for the treatment of inhalational anthrax to be used in combination with antibacterial drugs. Read More »

Amgen to present 19 abstracts including Repatha data at ACC 16

American Pharmacy News Reports | Mar 22, 2016
Amgen is set to present 19 abstracts at ACC 16 that will include Repatha data

Amgen has announced that it will present 19 abstracts associated with its cardiovascular portfolio that will include new data from the evaluation of Repatha (evolocumab) at the American College of Cardiology’s 65th Annual Scientific Session (ACC 16). Read More »

Cellectis and Takara sign supply and licensing agreement for RetroNectin

American Pharmacy News Reports | Mar 22, 2016
Cellectis has sign an agreement with Takara for the supplying and licensing of RetroNectin

Cellectis has entered into an agreement with Takara Bio Inc. for the supplying and licensing of RetroNectin, a recombinant human fibronectin fragment. Read More »

FDA announces opioid labeling changes as part of opioid abuse plan

American Pharmacy News Reports | Mar 22, 2016
The FDA has announced changes to opioid medication labels as part of its opioid abuse plan

The U.S. Food and Drug Administration (FDA) has announced labeling changes that will be required class-wide for immediate-release (IR) opioid pain medicines. Read More »

Rockwell’s Triferic drug submission accepted by China FDA

American Pharmacy News Reports | Mar 21, 2016
Rockwell's Triferic drug submission has been accepted by the China FDA

Rockwell Medical has announced that the China Food and Drug Administration (CFDA) has accepted its Triferic drug product submission. Read More »

ASHP Match program continues to grow

American Pharmacy News Reports | Mar 21, 2016
The ASHP's Match program to contuing to see rapid growth in applicants and positions

The ASHP’s Match program has continued to show progress and is continuing to grow at a rapid pace. Read More »

Advaxis publishes ADXS-HER2 study data

American Pharmacy News Reports | Mar 21, 2016
Advaxis has published the data from its ADXS-HER2 study

Advaxis has announced that data from its ADXS-HER2 dose-escalation study in canine osteosarcoma (OSA) has been published in Clinical Cancer Research, an online publication of the American Association for Cancer Research (AACR) on March 18. Read More »

  • «
  • 1
  • 2
  • ...
  • 106
  • 107
  • 108 (current)
  • 109
  • 110
  • ...
  • 167
  • 168
  • »
Trending

Shaun Noorian, CEO of Empower Pharmacy

Empower Pharmacy CEO: Big pharmaceutical companies pay 'to make rules that are in favor' of their company and 'stifle competition'

Jim Smith President

PCCA receives Texas governor's corporate champion award for community service

Stephen Sherry, Acting Director for the National Library of Medicine

National Library of Medicine says compounded medications offer alternatives for patients with unique medical needs

Jim Smith President

PCCA honors excellence in pharmacy compounding at annual awards ceremony

 B. Douglas Hoey CEO

NCPA urges careful consideration of pharma tariffs to prevent shortages and cost increases

Copyright © 2025 American Pharmacy News. All Rights Reserved.

  • About
  • Contact
  • Privacy Policy
  • Terms of Service

Alerts Sign-up